Literature DB >> 12886041

The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.

A Ahnaou1, A A H P Megens, W H I M Drinkenburg.   

Abstract

The atypical antipsychotics risperidone, clozapine and olanzapine were studied for their ability to antagonise apomorphine-induced stereotypy and to affect electroencephalographic (EEG) activity in rats. The compounds antagonised apomorphine-induced stereotypy with ED(50)s of 0.15 mg/kg s.c. for risperidone, 0.42 mg/kg s.c. for olanzapine and 1.3 mg/kg s.c. for clozapine. At a dose close to that required for apomorphine antagonism (0.16 mg/kg s.c.), risperidone induced only minor changes in EEG power spectral activity. At a higher dosage (0.63 mg/kg s.c.) it increased the power density in the high frequency range (9.8-18.6 Hz), characteristic of a sedative-like effect. Olanzapine and clozapine caused a dose-dependent increase in power density in all frequency bands. These effects were already present at doses (0.04 and 0.16 mg/kg s.c., respectively) 10 times below those required for apomorphine antagonism. The effects increased dose-dependently and were pronounced at the doses required for apomorphine antagonism. These results in rats are in agreement with the clinical observation that risperidone has less propensity for inducing sedation at therapeutic dose levels than olanzapine and clozapine. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886041     DOI: 10.1159/000071829

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  6 in total

1.  State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.

Authors:  Robert W Gould; Michael T Nedelcovych; Xuewen Gong; Erica Tsai; Michael Bubser; Thomas M Bridges; Michael R Wood; Mark E Duggan; Nicholas J Brandon; John Dunlop; Michael W Wood; Magnus Ivarsson; Meredith J Noetzel; J Scott Daniels; Colleen M Niswender; Craig W Lindsley; P Jeffrey Conn; Carrie K Jones
Journal:  Neuropharmacology       Date:  2015-11-23       Impact factor: 5.250

2.  Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Authors:  Nima Davoodi; Mikhail Kalinichev; Sergei A Korneev; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

3.  Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.

Authors:  Christina A Wilson; Alvin V Terry
Journal:  Pharmacol Biochem Behav       Date:  2012-12-31       Impact factor: 3.533

4.  Risperidone-induced Enuresis in a 12-year-old Child.

Authors:  Reetika Dikshit; Sagar Karia; Avinash De Sousa
Journal:  J Neurosci Rural Pract       Date:  2017 Jan-Mar

5.  Acute Metabolic Effects of Olanzapine Depend on Dose and Injection Site.

Authors:  Candice M Klingerman; Michelle E Stipanovic; Andras Hajnal; Christopher J Lynch
Journal:  Dose Response       Date:  2015-11-26       Impact factor: 2.658

6.  Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.

Authors:  A Ahnaou; H Huysmans; T Van de Casteele; W H I M Drinkenburg
Journal:  Transl Psychiatry       Date:  2017-12-18       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.